Corporate
2023.03.07
Lumosa Therapeutics Announces an Out-License Agreement with Pakistan’s AJM Pharma for LT1001
Corporate
2023.02.10
Lumosa Attending the 2023 International Stroke Conference
Corporate
2022.11.01
Lumosa Exhibiting at CPhI Frankfurt 2022
Corporate
2022.10.26
Lumosa Participating in 2022 World Stroke Conference Held in Singapore
Corporate
2022.10.12
Lumosa's CBO, Christopher Aleong, Serving as a Judge in the Startup Spotlight competition at Bio-Europe
Corporate
2022.10.03
Lumosa Beach Clean-up Day!